International quality control survey of neurochemical dementia diagnostics-Reference-Cited by-同舟云学术

International quality control survey of neurochemical dementia diagnostics

Published:2006-11 Issue:1 Volume:409 Page:1-4
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Lewczuk Piotr,Beck Georg,Ganslandt Oliver,Esselmann Hermann,Deisenhammer Florian,Regeniter Axel,Petereit Hela-Felicitas,Tumani Hayrettin,Gerritzen Andreas,Oschmann Patrick,Schröder Johannes,Schönknecht Peter,Zimmermann Klaus,Hampel Harald,Bürger Katharina,Otto Markus,Haustein Sabine,Herzog Karin,Dannenberg Rainer,Wurster Ulrich,Bibl Mirko,Maler Juan Manuel,Reubach Udo,Kornhuber Johannes,Wiltfang Jens

Publisher

Elsevier BV

Subject

General Neuroscience

Reference22 articles.

1. Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice;Andreasen;Arch. Neurol.,2001

2. Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier-mediated epitope masking of amyloid beta peptides;Bibl;Electrophoresis,2004

3. CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia;Bibl;Brain,2006

4. Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry;Davidsson;Rapid Commun. Mass Spectrom.,2002

5. High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype;Galasko;Arch. Neurol.,1998

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches;Journal of Extracellular Vesicles;2024-02

2. Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies;Journal of Extracellular Vesicles;2023-12-29

3. Measurement batch differences and between‐batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2021-01

4. Detection of Alzheimer Disease Pathology in Patients Using Biochemical Biomarkers: Prospects and Challenges for Use in Clinical Practice;The Journal of Applied Laboratory Medicine;2019-12-30

5. Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease;Neurology;2019-12-04